Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin

The risk of death due to heart disease and stroke is up to four times higher in individuals with diabetes compared to individuals without diabetes. Most guidelines that address treatment of dyslipidemia in patients with diabetes consider diabetes a cardiovascular disease (CVD) “risk equivalent” and...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinberg, Helmut, Anderson, Matt S, Musliner, Thomas, Hanson, Mary E, Engel, Samuel S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673969/
https://www.ncbi.nlm.nih.gov/pubmed/23761972
http://dx.doi.org/10.2147/VHRM.S44330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673969/
https://www.ncbi.nlm.nih.gov/pubmed/23761972
http://dx.doi.org/10.2147/VHRM.S44330

Ejemplares similares